azacitidine has been researched along with Choriocarcinoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, R; Xu, H; Xue, Y; Zeng, X; Zhang, T; Zhang, Y | 1 |
| Beristain, AG; Hogg, K; Robinson, WP | 1 |
| Lumbers, ER; Pringle, KG; Wang, Y | 1 |
| Chang, CC; Ferrone, S; Lin, AF; Yan, WH | 1 |
| Gluckman, PD; Lobie, PE; Mitchell, MD; Rahnama, F; Shafiei, F | 1 |
| Alizadeh, M; Boretto, J; Boucraut, J; Chimini, G; Fauchet, R; Guillaudeux, T; Le Bouteiller, P; Malecaze, F; Pontarotti, P; Semana, G | 1 |
| Barletta, JM; Feinberg, AP; Rainier, S | 1 |
| Boss, JM; Morris, AC; Spangler, WE | 1 |
8 other study(ies) available for azacitidine and Choriocarcinoma
| Article | Year |
|---|---|
Secreted Frizzled Related Protein 2 Modulates Epithelial-Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma.
Topics: Animals; Azacitidine; Cell Line, Tumor; Cell Movement; Choriocarcinoma; Decitabine; Dishevelled Proteins; DNA Methylation; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Humans; Matrix Metalloproteinase 2; Membrane Proteins; Mice; Mice, Nude; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Uterine Neoplasms; Wnt Signaling Pathway | 2018 |
Activation of endocrine-related gene expression in placental choriocarcinoma cell lines following DNA methylation knock-down.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aromatase; Azacitidine; Cell Line, Tumor; Choriocarcinoma; CpG Islands; Decitabine; DNA Methylation; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Leptin; Placenta; Pregnancy; Promoter Regions, Genetic; Receptors, Glucocorticoid; TEA Domain Transcription Factors; Transcription Factors; Uterine Neoplasms | 2014 |
The effects of cyclic AMP, sex steroids and global hypomethylation on the expression of genes controlling the activity of the renin-angiotensin system in placental cell lines.
Topics: Adult; Azacitidine; Cell Line, Tumor; Choriocarcinoma; Cyclic AMP; DNA Methylation; Drug Therapy, Combination; Estradiol; Female; Gene Expression Regulation, Developmental; Gene Silencing; Humans; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Trimester, First; Renin-Angiotensin System; Trophoblasts | 2013 |
Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
Topics: Azacitidine; Calreticulin; Cell Line, Tumor; Choriocarcinoma; Decitabine; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Humans; Melanoma; Methylation; Promoter Regions, Genetic; Transcription, Genetic | 2005 |
Epigenetic regulation of human trophoblastic cell migration and invasion.
Topics: Azacitidine; Cadherins; Cell Line, Tumor; Cell Movement; Choriocarcinoma; Decitabine; Desmoplakins; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Epigenesis, Genetic; Female; gamma Catenin; Humans; Promoter Regions, Genetic; Trophoblasts | 2006 |
HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR.
Topics: Azacitidine; Base Sequence; Choriocarcinoma; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation; Genes; Genes, MHC Class I; Histocompatibility Antigens Class I; HLA Antigens; HLA-E Antigens; In Vitro Techniques; Methylation; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Restriction Mapping; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1993 |
Reversal of loss of imprinting in tumor cells by 5-aza-2'-deoxycytidine.
Topics: Azacitidine; Choriocarcinoma; Colorectal Neoplasms; Decitabine; DNA Methylation; DNA Modification Methylases; Genomic Imprinting; Humans; Insulin-Like Growth Factor II; Muscle Proteins; RNA, Long Noncoding; RNA, Untranslated; Tumor Cells, Cultured | 1997 |
Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Choriocarcinoma; Decitabine; DNA Methylation; DNA Modification Methylases; Gene Expression Regulation; Genes, MHC Class II; Humans; Interferon-gamma; Molecular Sequence Data; Nuclear Proteins; Promoter Regions, Genetic; Trans-Activators; Transcription, Genetic; Trophoblasts; Tumor Cells, Cultured | 2000 |